August 25, 2016 6:52 AM ET

Pharmaceuticals

Company Overview of Roche Holding AG

Executive Profile

Michael D. Varney Ph.D.

Head of Genentech Research & Early Development, Roche Holding AG
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 5 different industries.

See Board Relationships
58--

Background

Mr. Michael D. Varney, also known as Mike, Ph.D. has been Head of Genentech Research & Early Development at Roche Holding AG since January 1, 2015. Mr. Varney serves as Executive Vice President of Genentech Research & Early Development of Genentech Inc. He served as Head of Small Molecule Drug Discovery and Co-Head of Genentech Research at Roche Holding AG until December 31, 2014. Mr. Varney served as Senior Vice President of Small Molecule Drug Discovery at Genentech ...

Corporate Headquarters

Konzern-Hauptsitz
Basel, Basel-Stadt 4070

Switzerland

Phone: 41 61 688 11 11
Fax: 41 61 691 93 91

Board Members Memberships

2015-Present
Director

Education

PhD
California Institute of Technology
BS
University of California-Los Angeles
Post-Doctoral Training
Columbia University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John F. Milligan Ph.D.Chief Executive Officer, President and Director
Gilead Sciences Inc.
$1.2M
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.9M
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
$5.2M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Roche Holding AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.